SEC Filings

Filing date	Form	Description	View
06/08/23	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-001432.pdf 0001950047-23-001432.rtf
05/23/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-008668.pdf 0001415889-23-008668.rtf 0001415889-23-008668.xls
05/23/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-008670.pdf 0001415889-23-008670.rtf 0001415889-23-008670.xls
05/23/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-008672.pdf 0001415889-23-008672.rtf 0001415889-23-008672.xls
05/23/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-008674.pdf 0001415889-23-008674.rtf 0001415889-23-008674.xls
05/23/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-008676.pdf 0001415889-23-008676.rtf 0001415889-23-008676.xls
05/18/23	10-Q/A	Amendment to a previously filed 10-Q	View HTML 0001558370-23-010149.pdf 0001558370-23-010149.rtf 0001558370-23-010149.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
05/17/23	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-23-008228.pdf 0001415889-23-008228.rtf 0001415889-23-008228.xls
05/15/23	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-23-000626.pdf 0001950047-23-000626.rtf 0001950047-23-000626.xls
05/10/23	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-23-008951.pdf 0001558370-23-008951.rtf 0001558370-23-008951.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.